Methodological issues of corticosteroid use in SLE clinical trials.
about
Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?A review of health related quality of life in systemic lupus erythematosus.Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis.Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).
P2860
Methodological issues of corticosteroid use in SLE clinical trials.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Methodological issues of corticosteroid use in SLE clinical trials.
@ast
Methodological issues of corticosteroid use in SLE clinical trials.
@en
type
label
Methodological issues of corticosteroid use in SLE clinical trials.
@ast
Methodological issues of corticosteroid use in SLE clinical trials.
@en
prefLabel
Methodological issues of corticosteroid use in SLE clinical trials.
@ast
Methodological issues of corticosteroid use in SLE clinical trials.
@en
P2860
P1433
P1476
Methodological issues of corticosteroid use in SLE clinical trials.
@en
P2093
M Corzillius
P2860
P304
P356
10.1191/096120399680411407
P577
1999-01-01T00:00:00Z